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Abstract
The type of a nucleic acid and the type of the cell to be transfected generally affect the efficiency of electroporation, the
versatile method of choice for gene regulation studies or for recombinant protein expression. We here present a combined
square pulse electroporation strategy to reproducibly and efficiently transfect eukaryotic cells. Cells suspended in a
universal buffer system received an initial high voltage pulse that was continuously combined with a subsequent low
voltage pulse with independently defined electric parameters of the effective field and the duration of each pulse. At
comparable viable cell recoveries and transfection efficiencies of up to 95% of all cells, a wide variety of cells especially
profited from this combined pulse strategy by high protein expression levels of individual cells after transfection. Long-term
silencing of gene expression by transfected small interfering RNA was most likely due to the uptake of large nucleic acid
amounts as shown by direct detection of fluorochromated small interfering RNA. The highly efficient combined pulse
electroporation strategy enables for external regulation of the number of naked nucleic acid molecules taken up and can be
easily adapted for cells considered difficult to transfect.
Citation: Stroh T, Erben U, Ku ¨hl AA, Zeitz M, Siegmund B (2010) Combined Pulse Electroporation – A Novel Strategy for Highly Efficient Transfection of Human
and Mouse Cells. PLoS ONE 5(3): e9488. doi:10.1371/journal.pone.0009488
Editor: Jo ¨rg Hoheisel, Deutsches Krebsforschungszentrum, Germany
Received November 24, 2009; Accepted February 8, 2010; Published March 2, 2010
Copyright:  2010 Stroh et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The study was supported by the following grants from the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.html): Si 749/5-1 ‘‘Histone
acetylation - epigenetic modification as regulator of the intestinal effector Th response’’ (to B.S.), as well as TP 12 ‘‘Mesenteric adipose tissue and the regulatory
function in intestinal inflammation’’ (to B.S.) and Z 1 ‘‘Development of systematic morphological methods for the evaluation of mucosal inflammations and the in-
situdetection of defined cell populations’’ (to M.Z.) of the Collaborative Research Center 633 ‘‘Induction and modulation of T cell-mediated immune response in
the gastrointestinal tract’’. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: britta siegmund@charite.de
Introduction
In the early 1980ies, upcoming recombinant techniques required
efficient introduction of nucleic acids into eukaryotic cells. Various
chemical, physical or virus-based transfection and transduction
strategies were developed [1,2]. Dependent on type and/or cell
cycle state of the target cell population, these techniques might
provide low transfer efficacies, be not suitable for non-adherent
cells, require toxic reagents, give limited accessto the nucleus, or are
time-consuming [3,4,5,6]. The application of strong electric fieldsto
form pores within biological membranes was described as early as
1965 [7]. Ever since the first description of myeloma cell
transfection [8], electroporation became the method of choice for
efficient transient transfection for numerous types of eukaryotic
cells. The so-called nucleofection combines electric pulses and
chemical transduction to direct for the nucleus [9].
For electroporation in general, the strength of the electrical field
applied and the pulse duration represent key parameters for
effective compound delivery as well as for target cell viability
[10,11,12]. Standard devices predominantly work with exponential
decay pulses where a capacitor is charged to an initial voltage and is
subsequently discharged through the cell suspension within a
cuvette. Here, the time constant of individual pulses results from the
capacity and overall resistance of the cell suspension. As for another
type of electric pulses, square wave pulses rely on a constant electric
field applied to the cell suspensions for a distinct time. Thus,
creation of square wave pulses requires a circuit to terminate
capacitor discharge after defined pulse duration. Compared to
single pulses, a combination of membrane permeabilization and
intracellular DNA transport by electrophoresis should increase
transfection efficacies for DNA [13]. Studies addressing transfec-
tions could demonstrate an improvement of pulse combinations in
contrast to single pulse strategies in vivo [14,15]. However, the
experimental situation in tissues differs significantly from conditions
invitro.Thusresultsnoteasilytransferfromonesystemtotheother.
In previous in vitro studies, a combination of high voltage (HV) and
low voltage (LV) pulses was advantageous if the pulses were
separated by gaps of 100 ms to 20 ms [16,17]. Here we present an
electroporation strategy with continuous combined HV and LV
square pulses where, using the modular ELPorator 1000 device, the
electric parameter of the effective field and the duration of each
pulse can be defined individually. This method allows for highly
efficient transfection of DNA or siRNA into isolated primary cell
populations or within mixed cell suspensions as well as into other
cell populations that are considered difficult to transfect. This
combined HV/LV strategy not only enables the transfer of high
amountsofmoleculespercellbutalsoallowstoexternallyregulating
the amount of transfected molecules.
Methods
Ethics Statement, Primary Cells and Cell Lines
Six- to eight-week old female C57BL/10 mice were from the
Charite ´ - Forschungseinrichtungen fu ¨r Experimentelle Medizin
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Berlin, Germany approved the animal protocols. Whole blood
samples from healthy donors were obtained with written consent
and with the approval of the local ethics committee of the
Charite ´ – Universita ¨tsmedizin Berlin. Peripheral blood mononu-
clear cells (PBMC) were prepared from the heparinized samples by
Ficoll density gradient centrifugation (GE Healthcare, Munich,
Germany). For staining of subpopulations directly labeled
monoclonal antibodies specific for CD4/clone 13B8.2, CD8/
clone BW135/80, CD14/clone MWP9 or CD19/clone HIB19
(BD Biosciences, Heidelberg, Germany) were used. The murine
cell lines 3T3L1 (ATCC CL-173) and J558L (ATCC TIB-6) were
from the American Type Culture Collection (Bethesda, MD); the
human cell lines K562 (ACC 10) and U937 (ACC 5) from the
Deutsche Sammlung von Mikroorganismen und Zellkulturen (Braunschweig,
Germany).
Isolation of Mouse Preadipocytes and Cell Culture
Murine preadipocytes were prepared and propagated up to ten
passages as previously described [18]. In brief, excised mesenteric
adipose tissue was minced and washed in HBSS. Tissue was
digested within 25 min at 37uC in HBSS containing 1.5 mg/ml
collagenase II, 3.5% BSA and 550 mM glucose. The cell
suspension was subsequently mashed through a 100 mm-nylon
net (BD Biosciences), sedimented at 200 g for 10 min and washed
twice in DMEM/HAMS F-12 containing 10% FCS and
penicillin/streptomycin (100 units/ml each). After 24 h incuba-
tion in 48-well plates (5610
5 cells/well), non-adherent cells were
discarded and adherent cell layers were propagated to establish
preadipocyte cell lines that were used up to the 10th passage. Cells
of the murine preadipocyte cell line 3T3L1 (ATCC CL-173) were
propagated in DMEM containing 10% FCS and penicillin/
streptomycin (100 units/ml each). The potential to give rise to
fully differentiated adipocytes from all preadipocyte cell lines used
in this study was confirmed by lipid droplet staining with Oil red O
after incubation with insulin, dexamethasone, and 3-isobutyl-1-
methylxanthine as described previously [19].
Electroporation of Eukaryotic Cells by the ELPorator 1000
Device
The complete ELPorator 1000 device consists of two modules,
generating independent square wave pulses that can be connected
electrically to generate a continuous combined pulse (Fig. 1A).
Module 1 provides voltages of 0–1.0 kV at a pulse length of 0–
999 ms; module 2 delivers 0–0.3 kV at a pulse length of 0–99 ms.
Both modules consist of a capacitor bank charged by a high
voltage power supply. Different output field strengths result from
different dimensions of the capacitor bank in each module (module
1: 110 mF; module 2: 940 mF). Electric charge stored in the
capacitor bank is delivered to the cuvette via an Insulated Gate
Bipolar Transistor (IGBT; Infineon, Munich, Germany). This high
performance semiconductor handles collector/emitter voltages up
to 1.2 kV, pulses collector currents up to 84 A and is controlled via
a Gate Resistor by an IGBT Driver (Avago Technologies, San
Jose, CA) which also enables for switching times in the nanosecond
range. An 8-bit Reduced Instruction Set Computing Microcon-
troller (Atmel, San Jose, CA) controls the IGBT driver.
Microcontroller programs in assembler language allow for user
defined pulse voltages and pulse length as input parameters
(Fig. 1B). The capacitors connected in series to resist voltages up to
1.2 kV and the IGBT are designed to handle overall high voltages
and currents. For safety reasons, a shunt resistor adjusts the
current flow through the cuvette. At current flows above 60 A, a
signal to the microcontroller activates the driver circuit and an
additional relay to immediately interrupt the pulse and to avoid
damages from an electric arc (Fig. S1). For combined HV/LV
pulses, modules 1 and 2 can be connected in parallel. Diodes at the
outputs prevent current overflow from module 1 into the lower
charged capacitor bank of module 2.
Figure 1. Definition of square wave pulses for eukaryotic cell transfection generated by the ELPorator 1000 device. (A) The ELPorator
1000 device consisting of two physically independent but electrically interconnectable modules. Module 1 produces single HV square wave pulse at a
maximum field strength of 5 kV/cm for 1–999 ms. Module 2 provides a single LV square wave pulse with up to 1.5 kV/cm in the range of milliseconds.
Combination of HV and LV square wave pulses forms an uninterrupted combined pulse. Preferentially, a LV pulse follows a primary HV pulse. Within
the ranges noted above, parameters of single or combined pulses can be defined individually. (B) Flow chart of input and output parameters within
the electronic components of the individual modules.
doi:10.1371/journal.pone.0009488.g001
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The expression vector pEGFP-N1 (GeneBank Accession
#U55762; 4,651 bp; Clontech, Mountain View, CA) was used
to assess plasmid transfection efficiencies. Plasmid preparations
from a standard anion-exchange method according to the
manufacturer’s instructions (Macherey-Nagel, Du ¨ren, Germany)
typically contained .95% covalently closed circular DNA. Cell
lines or murine preadipocytes from cell culture or freshly prepared
PBMC (1–3610
6) were resuspended in 100 ml electroporation
buffer containing 90 mM phosphate buffer, pH 7.2, 10 mM
MgCl2 and 50 mM glucose before 4 mg pEGFP-N1 were added.
Using an electroporation cuvette (2 mm gap; Lonza, Cologne,
Germany) in the ELPorator 1000 device, cells were subjected to a
single HV or LV, or to continuously combined HV/LV pulses
(Fig. 1A). Alternatively, 1610
6 3T3L1 cells or primary murine
preadipocytes were transfected in a Nucleofector I device (Lonza)
with the Cell Line V Nucleofector Kit and the T-030 program
according to the manufacturer’s protocol.
Immediately after pulse application, cells were transferred into
the respective pre-warmed standard culture medium containing
10% FCS and were incubated at 37uC for 24 h. Cells were
harvested and vital cell recovery assessed by trypan blue exclusion.
Transfection efficiencies as estimated by percentages of EGFP
+
cells and individual mean fluorescence intensity (MFI) values were
analyzed by flow cytometry using a FACSCanto II
TM device and
the FACSDiva
TM software (version 5.0.2; BD Biosciences,
Heidelberg, Germany).
Quantification of Glyceraldehyde-3 Phosphate
Dehydrogenase mRNA Using Plasmid Standard with a
Cloned Glyceraldehyde-3 Phosphate Dehydrogenase
Fragment
A fragmentofmurine glyceraldehyde-3phosphatedehydrogenase
(GAPDH) was amplified from cDNA of murine preadipocytes by
GAPDH-specific PCR using the primer pair 59–CATCCTGCA-
CCACCAACTGC–39/59–ACGCCACAGCTTTCCAGAGG–39
(TIB Molbiol, Berlin, Germany). The sequence cloned into the
vector pCR2.1 (Invitrogen, Karlsruhe, Germany) was verified
(Seqlab, Go ¨ttingen, Germany) to GenBank accession no. NM_
008084. The plasmid copy number of linearized DNA was calculated
from the concentration as determined by spectrophotometry using a
NanoDrop ND-1000 device (NanoDrop Technologies, Wilmington,
NC) and the molecular weight of the plasmid DNA. Single-use
aliquots were stored at 280uC. The PCR mixture contained 2 ml
plasmid standard, 2.5 pmol of sense and antisense primers and the
SYBR Green PCR Master Mix (Applied Biosystems, Foster City,
CA) in a total volume of 12.5 ml. Polymerase activation and target
amplification were performed using the following protocol: 10 min at
95uC, 35 cycles consisting of 15 sec at 95uC followed by 60 sec at
62uC using a StepOne Plus
TM Real-Time PCR System and the
instruments software (Applied Biosystems). For a quantification
standard curve, the coefficient of determination of a series of log10
dilutions from 1610
8 to 1610
2 GAPDH copies had to be at least
0.997. Copy numbers of GAPDH mRNA in experimental samples
were calculated from the cell count as determined by trypan blue
exclusion and individual crossing points from concomitant PCR.
Transfection with Small Interfering RNA
Preadipocytes (1610
6) were resuspended in 100 ml electropora-
tion buffer before GAPDH-specific (SilencerH Cy
TM3; Ambion,
Austin, TX) or Toll-like receptor (TLR) 4-specific (sense: 59-
GGAAGUUCACAUAGCUGAAdTdT-39, antisense: 59-UU-
CAGCUAUGUGAACUUCCdGdG-39; Qiagen, Hilden, Ger-
many) or control siRNA (sense: 59-UUCUCCGAACGUGU-
CACGUdTdT-39, antisense: 59-ACGUGACACGUUCGGAGA-
AdTdT-39; Qiagen, Hilden, Germany) was added and subjected
to single or continuously combined pulses as described above. As
to determine the efficacy of siRNA uptake and function,
knockdown of GAPDH expression was assessed from reversely
transcribed mRNA of defined cell numbers by quantitative PCR
using the plasmid standard and SYBR-Green. The effects of
siRNA on GAPDH expression was determined from reversely
transcribed mRNA that corresponds to 410 cells. Intracellular
presence of Cy3-labeled GAPDH-specific siRNA was directly
monitored by flow cytometry in propidium iodide negative cells.
One day after transfection with the TLR4-specific siRNA, cells
were stimulated with 1 mg/ml LPS the specific TLR4 ligand
[20]or with 200 nM lactyl-tetra-diaminopimelic acid (LT-DAP)
the specific ligand for the nucleotide oligomerization domain-1
[21]. After another 24 h, IL-6 production was determined from
the cell culture supernatants by Cytometric Bead Array (BD
Biosciences, Heidelberg, Germany) according to the manufactur-
er’s protocol.
Statistical Analysis
Significances were determined by two-sided t-tests using Prism 4
software for Windows (GraphPad Software, San Diego, CA).
Results
Permanent Cell Lines and Primary Adherent Cells as
Exemplified for Preadipocytes Can Be Effectively
Transfected by Combined HV/LV Pulses
Initial experiments established baseline standard conditions for
the application of combined HV/LV pulses compared to standard
transfection techniques. Independently varied parameters for
single HV and LV pulses or combined HV/LV pulses revealed
optimum transfection for 3T3L1 cells or primary murine
preadipocytes with an initial HV pulse of 3 kV/cm for 400 ms
followed without a gap by a LV pulse of 1.5 kV/cm for 5 ms. Cell
viability and transfection efficiency were compared with nucleo-
fection as an established electroporation method. Generally,
electroporation reduced viable cell numbers recovered after 24 h
of culture by about half compared to non-treated control cells
(Fig. 2, upper panel). Under conditions recommended for
nucleofection of 3T3L1 cells, transfection efficiencies as deter-
mined by the percentage of EGPF
+ cells were higher for the
3T3L1 cell line (91.561.3%) than for primary preadipocytes
(71.762.8%) (Fig. 2, lower panel). Using optimized combined
HV/LV pulses provided by the ELPorator 1000 device, both cell
types were transfected comparably (3T3L1: 95.061.3%; primary:
88.662.3%) and transfection efficiencies were significantly higher
than by nucleofection (3T3L1: p,0.05; primary: p,0.01). These
high percentages of transfected cells allowed e.g. for immediate
further experiments without enrichment procedures related to the
recombinant protein.
Transfection Efficiency of Electroporation Strictly
Depends Upon Pulse Composition and DNA Amounts
Cell-type specific effects of different pulse parameters were
assessed by single HV, single LV or combined HV/LV pulses
applied to 3T3L1 cells using the ELPorator 1000 device. A single
HV pulse gave rise to about 40% EGFP
+ cells (Fig. 3A).
Remarkably, a single LV pulse or a combined HV/LV pulse
resulted in significantly higher transfection efficiencies of approx-
imately 90% EGFP
+ cells. At first sight, these cells with a high
Combined Pulse Electroporation
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combined pulse strategy for transfection with plasmid DNA. If
focusing on cellular expression levels of the recombinant protein, a
single HV pulse again was inferior for transfection compared to
the other strategies. In contrast to the findings with percentages of
EGFP
+ cells, mean fluorescence intensity (MFI) values determined
by flow cytometry to assess intracellular fluorescent protein
expression levels were significantly higher with the combined
HV/LV pulse compared to the single LV pulse. These findings
underline the importance of externally modifiable pulse properties
to optimize uptake and define intracellular fate of given DNA
amounts.
Next, we asked how DNA amounts affect transfection efficiency
(Fig. 3B). Despite a slight increase from 30.460.9% EGFP
+ cells
with 2 mg DNA to 52.060.5% with 12 mg DNA, recombinant
protein expression levels remained unchanged if increasing
amounts of plasmid DNA were used with a single HV pulse for
electroporation. With the combined HV/LV pulse strategy, 4 mg
DNA sufficiently transfected all preadipocytes and this plateau
level was not altered by increasing amounts of DNA, as
determined with up to 12 mg plasmid DNA. Comparable to
varied pulse parameters, EGFP expression levels increased with
DNA amounts up to 8 mg until a MFI plateau level of
167.5610
363.5610
3 arbitrary units was reached. This DNA
dose dependency indicated that transfection efficiencies to be
obtained employing the ELPorator 1000 device could be
modulated by the electrical conditions as well as by the plasmid
DNA amount to be transfected.
Combined Continuous HV/LV Pulse Strategy Allows for
Efficient Transfection of Suspension Cell Lines
The murine myeloma cell line J588L, the human erythromye-
loblastoid leukemia cell line K562 and the human histiocytic
lymphoma cell line U937, all suspension cells frequently used for
recombinant protein expression or to study phenomena related to
malignant transformation or cellular differentiation were treated
with a combined HV/LV pulse to transfect 4 mg standard plasmid
DNA. These cells were efficiently transfected with a uniform set of
electric parameters for a combined HV/LV pulse (Table 1). More
than 90% of the J558L and K562 cells were EGFP
+ with high
cellular fluorescent protein expression levels as shown by MFI
values of about 10
5 arbitrary units. Of the usually difficult to
transfect U937 cells, 79.160.5% were EGFP
+ with intermediate
EGFP expression. The cell loss of about a third of the J558L or
K562 cells and of about half of the U937 cells after application of a
combined HV/LV pulse with the ELPorator 1000 device, was
recompensed by high transfection efficiencies. Overall recovery of
vital cells after transfection of these three suspension cell lines was
higher applying single HV pulses, but accompanied by lower MFI
values. With exception of the U937 cell line where transfection
efficiency as determined by percentages of EGFP
+ cells was nearly
doubled (45.5 vs. 79.1; MFI: 9.4610
3 vs. 42.1610
3) (Fig. S2), a
combined HV/LV did not markedly affect the number of
transfected cells compared to a single HV pulse. As shown for
adherent cells (Fig. 3), the key benefit of the combined pulse
strategy was an increase in recombinant intracellular fluorescent
protein levels. For example, applying a HV/LV pulse to J558L
myeloma cells, the expression level of EGFP was about four times
higher in comparison to levels that could be reached if only using a
single HV pulse (MFI: 95.5.x10
3 vs. 29.6610
3) (Fig. S2).
Immune Cells in Mixed Peripheral Blood Mononuclear
Cell Preparations Are Efficiently and Subtype-
Dependently Transfected by a Strategy of Combined HV/
LV Pulses
Freshly isolated PBMC comprise interesting cell populations e.g.
to study immune cell-mediated mechanisms against the background
of defined major histocompatibility complex molecules. We asked
whether the main subpopulations of T and B lymphocytes or
monocytes within mixed PBMC preparations were efficiently
recovered and transfected for recombinant protein expression if
treated with single HV or combined HV/LV pulses. Recovery of
subpopulations after transfection was estimated by specific staining
and flow cytometry analysis (Fig. 4A). Percentages of CD4
+ T cells
were marginally increased after HV or combined HV/LV pulses,
while the proportions of CD8
+ T cells were not affected by
transfection. CD19
+ cells showed a distinct decrease, identifying B
cells to be more sensitive to transfection conditions applied.
Transfection efficiency as estimated by percentages of EGFP
expressing cells was comparable in all lymphocyte subpopulations.
A combined HV/LV transfection condition slightly increased the
transfection efficiency of CD8
+ and CD19
+ cells compared to the
single pulse but had no effect on CD4
+ cells. Again, after applying a
combined HV/LV pulse the cellular EGFP expression level was
significantly higher in all subpopulations investigated, while the
additional LV pulse did not reduce overall cell recovery (Fig. 4B).
CD14
+ cells within the mixed PBMC populations proved to be very
sensitive to HV or HV/LV pulses. Although under the conditions
described,up to 98% of the CD14
+ cellsweredepleted,howeverthe
surviving monocytic cells were sufficiently transfected. Thus,
efficient transfection of freshly prepared PBMC might compensate
for the need of further time-consuming procedures to isolate specific
Figure 2. Transfection efficiency for adherent cells achieved by
nucleofection compared to the ELPorator 1000 device. For
transfection of 1610
6 3T3L1 cells or preadipocytes from the mesenteric
fat with 2 mg pEGFP-N1, a pulse combined of a HV pulse of 3 kV/cm for
400 ms followed by a LV pulse of 1.5 kV/cm for 5 ms was applied by the
ELPorator 1000 device. Alternatively, cells were transfected using the
Nucleofector Kit V and program T-030 in a device for nucleofection or
remained untreated. After 24 h, cell recovery and viability were
assessed by trypan blue exclusion. Transfection efficiency was
determined by flow cytometry as percentage of EGFP
+ cells. Mean
values 6 SEM; n=5.
doi:10.1371/journal.pone.0009488.g002
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discrimination of immune cell subpopulations. Reasonable trans-
fection efficiencies render this an interesting approach even for
primary CD14
+ cells if they can be further distinguished from other
of PMBC subpopulations.
Transfection with Combined HV/LV Pulses Grants Long-
Lasting Gene Knockdown by Efficient Delivery of siRNA
As for a model system for knockdown with the siRNA
molecules, primary murine preadipocytes were transfected with
120 pmol siRNA specific for GAPDH by a single HV pulse or a
combined HV/LV pulse. Independent of the pulse strategy,
GAPDH-specific siRNA revealed reduced copy numbers of
GAPDH mRNA compared to a non-coding control siRNA after
24 h (Fig. 5A, upper panel) and 48 h (Fig. 5A, middle panel). Even
after 72 h, copy numbers of GAPDH-specific mRNA remained
significantly reduced (Fig. 5A, lower panel). Here in a time span
interesting for transient but long-term knockdown, the combined
HV/LV pulse (p,0.001) was more efficient than the single HV
pulse (p,0.05). To correlate the efficiency of siRNA uptake
directly with the efficiency of GAPDH-specific knockdown,
transfected GAPDH-specific siRNA was visualized by flow
cytometry via a fluorescent Cy3 label (Fig. 5B). Five hours after
transfection with GAPDH-specific siRNA using a single HV pulse,
MFI values were only slightly higher than for non-transfected
preadipocytes. However, the amount of cell-associated Cy3 was
significantly increased by about 7-fold if labeled siRNA was
delivered using the combined HV/LV pulse strategy. As for an
additional functional readout, preadipocytes transfected with a
TLR4-specific siRNA showed significantly reduced IL-6 secretion
upon stimulation with LPS compared to the controls. Emphasizing
the specificity of the TLR4 knock-down, stimulation with the
specific ligand for nucleotide oligomerization domain-1, a related
intracellular receptor, was not altered by transfection with TLR4-
specific siRNA compared to cells that received the control siRNA
(Fig. 6). These findings not only underline the advantages of the
combined square pulse strategy, technically realized with the
ELPorator 1000 device, but also confirmed the concept that
efficiency and duration of a specific knockdown directly depend on
the amount of intracellular siRNA.
Table 1. Transfection efficiencies and viable cell recovery in
suspension cell lines.





(% of all cells) MFI (x10
3)
J558L 92.260.5 95.5610.0 6.460.8 4
K562 95.060.6 107.2610.4 7.360.8 3
U937 79.160.5 42.162.7 4.360.5 4
Suspension cells from standard cultures (1610
6) were transfected with 4 mg
pEGFP-N1 vector using a combined HV/LV pulse (3 kV/cm, 100 ms and 750 V/
cm, 10 ms) applied by the ELPorator 1000 device. After 24 h, transfection
efficiency was determined by flow cytometry from the percentages of EGFP
+
cells and from individual EGFP expression levels. Viable cell recovery was
assessed by trypan blue exclusion. Mean values 6 SEM.
doi:10.1371/journal.pone.0009488.t001
Figure 3. Impact of pulse composition and plasmid DNA amount on the transfection efficiency for primary murine preadipocytes.
(A) 3T3L1 cells were transfected with 2 mg pEGFP-N1 using the ELPorator 1000 device for single HV or LV pulses or for a combined HV/LV pulse (HV:
3 kV/cm, 400 ms; LV: 1.5 kV/cm, 5 ms). Efficiency was estimated by flow cytometry from the percentages of EGFP
+ cells and from individual EGFP
expression levels after 24 h. Mean values 6 SEM, n=2. (B) Primary murine preadipocytes were transfected with different amounts of pEGFP-N1 vector
using a single HV pulse (3 kV/cm, 400 ms; white circles) or a combined HV/LV pulse (3 kV/cm, 400 ms and 1.5 kV/cm, 5 ms; black circles). Transfection
efficiency was determined from the percentages of EGFP
+ cells and EGFP expression levels after 24 h. Mean values 6 SEM; n=3.
doi:10.1371/journal.pone.0009488.g003
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The modular ELPorator 1000 device grants controlled, external
presetting of field strength and pulse length of square pulses, basic
electric parameters that define the transfection efficiency for
eukaryotic cells. In addition, this configuration allows uninter-
rupted combined HV and LV pulses that help to optimize
conditions with regard to the nature of the cell populations and of
the nucleic acids to be transfected. This individualized approach
facilitates not only the transfection of a wide variety of cell types,
but results in profound and long-lasting gene suppression after
siRNA transfection. As for an established technique to efficiently
transfect eukaryotic cells with DNA, nucleofection represents a
variant of electroporation providing fixed electrical conditions in
combination with specific buffer compositions [2,9,22,23]. Trans-
fection efficiencies improved under optimized conditions applying
combined HV/LV square pulses using a standard universal
phosphate buffer system as shown for preadipocytes (Fig. 2). How
might combined HV/LV square pulses become advantageous for
distinct cell populations? The high field strength of short HV
pulses is thought to be sufficient to create pores that overall
increase cell membrane permeability for large molecules [24,25].
A LV pulse is considered to maintain pores without negative
effects on the cell integrity for a given prolonged time, and thus
allows for an electrophoretic transport of electrically charged
molecules like nucleic acids [13]. Two earlier studies addressed the
question whether joining these phenomena in a double pulse
consisting of a HV pulse and a LV pulse is superior to single pulse
strategies for eukaryotic cell transfection. Although ambiguous in
the outcomes, a benefit of the double pulse strategies that included
defined breaks between the HV and the LV square pulse seemed
to be limited to experimental settings with low DNA amounts
[16,17]. We here relied on combined pulses where the LV pulse
immediately followed the HV square pulse in terms of downsizing
the field strength without interrupting the application of the
electric field itself (Fig. 1). Using this approach, our study
emphasizes the necessity to individualize and to control electrical
conditions as well as to adapt the parameters along cell
morphology and physiology, rather than the buffer conditions
during electroporation. For cells with high cytoplasm/nucleus
ratios, a single LV pulse was more efficient than a single HV pulse
in transfecting e.g. primary preadipocytes with plasmid DNA. The
combined HV/LV pulse strategy again significantly increased the
transfection efficacy as determined by the percentage of transfect-
ed cells and by the expression levels of the recombinant protein in
individual cells (Fig. 3). Having low cytoplasm/nucleus ratios like
Figure 4. Transfection efficiency of defined lymphocytic and monocytic cell subpopulations within mixed human peripheral blood
mononuclear cells. Freshly prepared human PBMC (3610
6) were transfected with 4 mg pEGFP-N1. A single HV pulse of 4.5 kV/cm for 400 mso r
combined with a LV pulse of 0.75 kV/cm for 3 ms was applied by the ELPorator 1000 device. Non-treated PBMC served as controls. (A) Cells were
incubated with directly labeled monoclonal antibodies and overall distribution of the subpopulations within mixed PBMC preparations, percentages
of EGFP
+ cells, and EGFP expression levels within the individual populations were determined by multi-color flow cytometry after 24 h. Mean values
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efficiencies using standard nucleofection conditions for total
PBMC preparations were found to be in the range of 30–70%
of all cells [26]. In our hands, the main proportion of the cells was
transfected with given DNA amounts using a short single HV
pulse. PBMC profited from a combined HV/LV pulse strategy
showing enhanced individual expression levels of the recombinant
protein (Fig. 4). We specifically did not aim to prove superiority to
other electroporation methods but to clearly comprehend
experimental conditions for the transfection of different cells using
a combined pulse electroporation strategy.
Emphasizing that the efficient uptake of large amounts of
nucleic acids under the field conditions of combined HV/LV
pulses provided by the ELPorator 1000 device and not the
promotor strength alone was responsible for the high expression
levels, cells transfected with a combined HV/LV pulse contained
significant amounts of fluorochrome-labeled siRNA as directly
quantified by flow cytometry (Fig. 5A). Due to its small size, siRNA
effectively enters eukaryotic cells upon chemical transfection, but
inclusion within cytoplasmic vesicles might render siRNA
inaccessible for down-regulation of gene expression [27,28]. After
electroporation using the combined HV/LV pulse strategy, no
vesicle formation was observed and the transfected specific siRNA
significantly suppressed model gene expression for up to 72 h
(Figs 5 and 6); a time span suitable for experimental approaches
that include specific knockdown.
Thus, with independently controllable but combined HV/LV
square pulses efficient transfection of eukaryotic cells with plasmid
DNA or siRNA can be easily established for cells where no
standardized protocols exist so far, simply by modifying field
strength and pulse length of the HV as well as a potential
Figure 5. Long-term outcome of transfection of primary preadipocytes with GAPDH-specific siRNA. Primary preadipocytes were
transfected with 120 pmol Cy3-labeled GAPDH-specific siRNA or a non-coding siRNA for control using a single HV pulse (3 kV/cm, 400 ms) or a
combined HV/LV pulse (3 kV/cm, 400 ms and 1.5 kV/cm, 5 ms) produced by the ELPorator 1000 device. (A) After 24, 48 and 72 h, copy numbers of
GAPDH-specific mRNA were determined by quantitative PCR in comparison to a cloned plasmid standard. Mean values 6 SEM; n=6. (B) As directly
assessed by flow cytometry 5 h after transfection, uptake of Cy3-labeled GAPDH-specific siRNA by preadipocytes was determined via the MFI.
Representative histogram and mean values 6 SEM; n=4.
doi:10.1371/journal.pone.0009488.g005
Figure 6. Functionality of siRNA in transfected cells. Primary
preadipocytes were transfected with 100 pmol TLR4-specific siRNA or
non-coding control siRNA using the combined HV/LV pulse strategy
(3 kV/cm, 400 ms; 1.5 kV/cm, 5 ms). One day after transfection, cultures
received 1 mg/ml LPS or 200 nM LT-DAP for additional 24 h before IL-6
production was determined from the cell culture supernatants. Bars
represent the mean of n=3 6 SEM.
doi:10.1371/journal.pone.0009488.g006
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electroporation. This cell type-dependent rational approach
provides additional insights to physical prerequisites for optimum
transfection and typically results in high transfection efficiencies
accompanied by good cell viability. Since our technical solution
allows profound and long-lasting gene suppression after transfec-
tion of specific siRNA, we anticipate its use for a broad spectrum
of normally hard-to-transfect cell populations including primary
cells, and for a variety of siRNA applications.
Supporting Information
Figure S1 Composition of the ELPorator 1000 device. Elec-
tronic composition of the output stage of the HV module. MC,
microcontroller; OC, optical coupler; RG, gate resistor; T,
transistor; RS, shunt resistor, D, diode; Rel, relay; C, capacitor
(upper panel). Picture shows the complete ELPorator 1000 system
(lower panel). Outputs of both modules are parallel connected via
internal diodes to prevent current flow from one module to the
other. The signal to trigger the LV module is generated by the
microcontroller of the HV module and sent via a control cable at
the backside of the module.
Found at: doi:10.1371/journal.pone.0009488.s001 (0.58 MB TIF)
Figure S2 Transfection efficiencies for plasmid DNA to
suspension cells after applying a single HV or a combined HV/
LV pulse. Suspension cells from standard cultures (1610
6) were
transfected with 4 mg pEGFP N1 vector using a single HV pulse
(3 kV/cm, 400 ms; bold line) or a combined HV/LV pulse (3 kV/
cm, 100 ms and 750 V/cm, 10 ms; gray area) applied by the
ELPorator 1000 device. After 24 h, the transfection efficiency was
determined by flow cytometry from the percentages of EGFP
+
cells and from individual EGFP expression levels according to the
MFI values. Light lines show the respective negative control.
Viable cell recovery was assessed by trypan blue exclusion. Values
given in individual columns are: EGFP
+ cells as percentage of all
cells; MFI x10
3; viable cell recovery x10
5. Data are representative
for at least three comparable experiments done in triplicates.
Found at: doi:10.1371/journal.pone.0009488.s002 (0.15 MB TIF)
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